Diet, Genetic Variation and Prostate Cancer Among African Americans

This study has been completed.
Sponsor:
Information provided by:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT00584792
First received: December 22, 2007
Last updated: NA
Last verified: December 2007
History: No changes posted
  Purpose

This is a single center pilot study to asses the feasibility of conducting a larger population-based study. It is an investigator-initiated study funded yb the UC Davis Cancer Center's Development Award Program. The hypothesis is that the percent african ancestry in an individual may determine their prognosis if diagnosed with prostate cancer.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Diet, Genetic Variation and Prostate Cancer Among African Americans

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • Is there a difference in ancestry percentage between the controls (no cancer) and the cases (prostate cancer) [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Serum collected for Ancestry Imformative Markers (AIMS) testing along with PSA and CRP.


Enrollment: 102
Study Start Date: August 2006
Study Completion Date: December 2007
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Controls (No prostate cancer)
2
Cases (Prostate Cancer Diagnosed)

  Eligibility

Ages Eligible for Study:   35 Years to 75 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

African American males between the ages of 35 and 75.

Criteria

Inclusion Criteria:

Self-identification as a male with African ancestry Between ages of 35-75

Exclusion Criteria:

No African ancestry Not between ages of 35-75

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00584792

Sponsors and Collaborators
University of California, Davis
Investigators
Principal Investigator: Lesley Butler, PhD University of California, Davis
  More Information

No publications provided

Responsible Party: Lesley Butler, PhD, University of California, Davis
ClinicalTrials.gov Identifier: NCT00584792     History of Changes
Other Study ID Numbers: 200614379, AA Pilot Study
Study First Received: December 22, 2007
Last Updated: December 22, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Davis:
Prostate Cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on July 20, 2014